Drug Discovery Informatics Market Size, Top Share, Demand

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Drug Discovery Informatics Market Size Analysis

Global Drug Discovery Informatics Market Introduction
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modelling
  1. By Value
4. Docking
  1. By Value
5. Clinical Trial Data Management
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Discovery Informatics
  1. By Value
3. Biocontent Management
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. CROs & CMOs
  1. By Value
4. Academic & Research Institutes
  1. By Value

North America Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modelling
  1. By Value
4. Docking
  1. By Value
5. Clinical Trial Data Management
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Discovery Informatics
  1. By Value
3. Biocontent Management
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. CROs & CMOs
  1. By Value
4. Academic & Research Institutes
  1. By Value
U.S.
1. By Service
  1. Introduction
    1. Service By Value
  2. Sequence Analysis Platforms
    1. By Value
  3. Molecular Modelling
    1. By Value
  4. Docking
    1. By Value
  5. Clinical Trial Data Management
    1. By Value
  6. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Discovery Informatics
    1. By Value
  3. Biocontent Management
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. CROs & CMOs
    1. By Value
  4. Academic & Research Institutes
    1. By Value
Canada

Europe Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modelling
  1. By Value
4. Docking
  1. By Value
5. Clinical Trial Data Management
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Discovery Informatics
  1. By Value
3. Biocontent Management
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. CROs & CMOs
  1. By Value
4. Academic & Research Institutes
  1. By Value
U.K.
1. By Service
  1. Introduction
    1. Service By Value
  2. Sequence Analysis Platforms
    1. By Value
  3. Molecular Modelling
    1. By Value
  4. Docking
    1. By Value
  5. Clinical Trial Data Management
    1. By Value
  6. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Discovery Informatics
    1. By Value
  3. Biocontent Management
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. CROs & CMOs
    1. By Value
  4. Academic & Research Institutes
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modelling
  1. By Value
4. Docking
  1. By Value
5. Clinical Trial Data Management
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Discovery Informatics
  1. By Value
3. Biocontent Management
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. CROs & CMOs
  1. By Value
4. Academic & Research Institutes
  1. By Value
China
1. By Service
  1. Introduction
    1. Service By Value
  2. Sequence Analysis Platforms
    1. By Value
  3. Molecular Modelling
    1. By Value
  4. Docking
    1. By Value
  5. Clinical Trial Data Management
    1. By Value
  6. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Discovery Informatics
    1. By Value
  3. Biocontent Management
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. CROs & CMOs
    1. By Value
  4. Academic & Research Institutes
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modelling
  1. By Value
4. Docking
  1. By Value
5. Clinical Trial Data Management
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Discovery Informatics
  1. By Value
3. Biocontent Management
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. CROs & CMOs
  1. By Value
4. Academic & Research Institutes
  1. By Value
UAE
1. By Service
  1. Introduction
    1. Service By Value
  2. Sequence Analysis Platforms
    1. By Value
  3. Molecular Modelling
    1. By Value
  4. Docking
    1. By Value
  5. Clinical Trial Data Management
    1. By Value
  6. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Discovery Informatics
    1. By Value
  3. Biocontent Management
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. CROs & CMOs
    1. By Value
  4. Academic & Research Institutes
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modelling
  1. By Value
4. Docking
  1. By Value
5. Clinical Trial Data Management
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Discovery Informatics
  1. By Value
3. Biocontent Management
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. CROs & CMOs
  1. By Value
4. Academic & Research Institutes
  1. By Value
Brazil
1. By Service
  1. Introduction
    1. Service By Value
  2. Sequence Analysis Platforms
    1. By Value
  3. Molecular Modelling
    1. By Value
  4. Docking
    1. By Value
  5. Clinical Trial Data Management
    1. By Value
  6. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Discovery Informatics
    1. By Value
  3. Biocontent Management
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. CROs & CMOs
    1. By Value
  4. Academic & Research Institutes
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Drug Discovery Informatics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Certara
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Boehringer Ingelheim International GmbH
Infosys Ltd.
Charles River Laboratories
Collaborative Drug Discovery, Inc.
Eurofins DiscoverX Products
Jubliant Biosys
Selvita
Novo Informatics Pvt. Ltd.
ChemAxon Ltd.
Albany Molecular Research Inc.
Oracle
Accenture
Agilent Technologies, Inc.
Illumina, Inc.
Novo Nordisk
Takeda Pharmaceutical
Nabla Bio
Lila Sciences
SandboxAQ
Elix, Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment